Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Clinical Services: To outsource or To Not Outsource, That Is the Question

When providers think of purchased services, their minds typically go to facility support, IT, and ancillary services. However, this  scope is too limited and doesn’t encompass the full breadth of what falls under the definition of purchased services. The fact is, there are over 250 clinical services that are categorized as a purchased service including pharmacy compounding…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

When providers think of purchased services, their minds typically go to facility support, IT, and ancillary services. However, this scope is too limited and doesn’t encompass the full breadth of what falls under the definition of purchased services. The fact is, there are over 250 clinical services that are categorized as a purchased service including pharmacy compounding services, dialysis services, imaging services, and neurology services.

Another way to describe this is to say that all “clinical services” could potentially be a purchased service, but are not necessarily the the most commonly known purchased services categories such as lawn care, medical waste disposal, or courier services that hospital administrators typically outsource. Because clinical services can be performed by skilled clinicians within the hospital, it can be challenging for healthcare organization leaders to determine whether or not outsourcing these types of services will affect quality of care and ultimately the total costs to serve patients.

Let’s take a closer look at the items found under the “clinical services” umbrella and identify both the questions to ask and typical tasks to perform to determine whether or not they should be outsourced. As with all decisions involving purchased services, but perhaps even more so with services that fall under the clinical category, the goal of choosing to outsource, is to help your healthcare organization save money while continuing to provide the high standard of care your patients expect.

  1. Start by comparing costs: Clinical services, like other purchased services categories, must be either outsourced or performed by facility personnel. Many providers should begin by comparing department profit and loss versus an outsourced firm’s cost model to determine what makes the most sense for each given department. There will likely not be a one-size-fits-all
  1. Perform clinical oversight: Though other purchased services areas may need little oversight, clinical services that are outsourced will need regular and rigorous clinical oversight to ensure they run smoothly and consistently attain the desired results. Department leaders in clinical areas must perform regular analysis of an outsourced firm’s results to determine whether their costs and patient outcomes have changed. Incorporating these data points into regularly scheduled Value Analysis Team (VAT) meetings will ensure consistent quality and outcomes.
  1. Find out if your outsourced firm has best-in-class results:Providers that outsource clinical areas are attempting to obtain the scale and best practices of the outsourced firm. Therefore, it is imperative that clinical leaders and supply chain leaders leverage the data and scale of their outsourced firm to achieve best-in-class results and continuous improvement. Don’t settle for “good enough.”
  1. Schedule regular reviews: Setting an outsourced service on autopilot won’t yield stellar results. Partnering with the outsourced service provider to review optimization opportunities and key performance data will help with continuous improvement and determine that the value of outsourcing isn’t falling away over time.

Every year, hospitals in America waste more than $50 billion on healthcare purchased services—including clinical services. Uncover millions in savings easier and faster with Valify. Valify is the only 100% dedicated web-based solution that allows healthcare organizations to quickly identify, benchmark and track savings in hospital purchased services.

Read more at getvalify.com

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's Healthcare expertise into the articles, video, and social content B2B marketing buyers in your industry are searching for. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Tempus AI's $1.7B Personalis deal leads a surge in health-tech M&A that is already reshaping vendor choices for health system operators

Tempus AI's $1.7B Personalis deal leads a surge in health-tech M&A that is already reshaping vendor choices for health system operators

Digital health mergers and acquisitions (M&A) along with venture capital (VC) activities are rapidly increasing. Tempus AI's $1.7 billion acquisition of Personalis is part of a larger trend that is influencing health system operators’ selection of vendors. With $7.4 billion in funding during the first half of 2026, the health-tech industry is undergoing significant transformation.

  • 01Tempus AI acquired Personalis for $1.7 billion.
  • 02Health-tech received $7.4 billion in funding in the first half of 2026.
  • 03M&A activities are influencing vendor choices for health system operators.

Jul 30, 2026

Digital health AI investment hits $7.4B in H1 2026 as CMS, hospitals, and startups all accelerate adoption

Digital health AI investment hits $7.4B in H1 2026 as CMS, hospitals, and startups all accelerate adoption

In the first half of 2026, digital health AI investments reached $7.4 billion as organizations like CMS, hospitals, and startups increased their adoption of AI. Significant moves include the establishment of a new CMS technology office and a $1.7 billion acquisition in cancer technology. These developments mark an enterprise-level commitment to advancing AI in healthcare.

  • 01Digital health AI investments reached $7.4 billion in H1 2026.
  • 02The CMS established a new technology office to advance healthcare AI.
  • 03A major acquisition in cancer technology totaled $1.7 billion.

Jul 30, 2026

Sensor networks and AI push structural health monitoring toward a $8.6 billion market by 2035

Sensor networks and AI push structural health monitoring toward a $8.6 billion market by 2035

The global structural health monitoring (SHM) market is projected to surpass $8.6 billion by 2035. This growth is fueled by the integration of AI analytics, wireless sensor technologies, and the necessity to address aging infrastructure. The expansion reflects a widespread adoption of these technologies in various sectors.

  • 01The SHM market is expected to exceed $8.6 billion by 2035.
  • 02Advancements in AI-powered analytics and wireless sensors are key drivers of market growth.
  • 03Aging infrastructure is creating a demand for enhanced structural health monitoring solutions.

Jul 24, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512